NovaBay Pharmaceuticals to Distribute the NuLids System® for the Treatment of Dry Eye in Certain U.S. Geographies
Retrieved on:
Monday, October 28, 2019
Medical devices, Infectious diseases, Health, Pharmaceutical, Optical, Medical specialties, Medicine, Ophthalmology, Blepharitis, RTT, Meibomian gland, Eyelid, Eyelash, Dry eye syndrome, Optometry, Blepharoplasty, BlephEx, NovaBay Pharmaceuticals, Inc.: Going Beyond Antibiotics®, NuSight Medical®: Comfort in the Blink of an Eye
The NuLids System is a hand-held, cordless device that safely and effectively removes accumulated scurf from eyelashes and eyelids, while stimulating meibomian gland production in dry eye and blepharitis patients.
Key Points:
- The NuLids System is a hand-held, cordless device that safely and effectively removes accumulated scurf from eyelashes and eyelids, while stimulating meibomian gland production in dry eye and blepharitis patients.
- We further believe the NuLids System will elevate our sales calls with ophthalmologists and optometrists and make our salespeople more productive.
- We expect to begin selling the NuLids System at the beginning of November in the greater mid-Atlantic region.
- The NuLids System is the unique, patented, mechanical device that is directed by eye care practitioners for the home-based treatment of Dry Eye Disease and Blepharitis.